The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Monday broker round-up

Mon, 02nd Sep 2019 13:16

(Sharecast News) - Beazley: UBS upgrades to buy with a target price of 650p.

Anglo Pacific Group: Berenberg reiterates buy with a target price of 226p

Hurricane Energy: Berenberg reiterates buy with a target price of 100p.

John Wood: Berenberg reiterates buy with a target price of 540p.

Kenmare Resources: Berenberg reiterates buy with a target price of 400p.

Gulf Keystone Petroleum: Peel Hunt reiterates buy with a target price of 391p.

AstraZeneca: Deutsche Bank reiterates buy with a target price of 7,600p.

GlaxoSmithKline: Deutsche Bank reiterates hold with a target price of 1,645p.

Related Shares

More News

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...